debentures which will lead to a decreased finance cost as well as more financial stability and liquidity. 4.2 Possibility of the plan to use capital from the rights offering The Company expects the issuance
) N/A - N/A (1,487) - N/A Profit (loss) from operating activities (508) (4,311) 88% 965 -153% (4,819) 1,614 -399% Finance costs (517) (464) 12% (421) 23% (981) (864) 14% Impairment gain and reversal of
finance costs due to higher borrowings as a result of previous investments in machinery, subsidiaries, and joint ventures. 2. Overview of Domestic Economy and Ready-to-Drink Fruit Juice Market In Q3/2018
% Revenue from finance lease under power purchase agreement 102.9 102.8 103.2 0.4% 0.3% 308.4 306.9 (0.5%) Revenue from construction under a concession arrangement 21.2 398.1 215.0 (46.0%) 914.2% 89.7 744.4
%. The change due to there was donation from selling of brooch in 2017 Decreasing in finance cost is because all loans was settled since 1st quarter 2018. For the year ended 31 Dec The company has
116.29%. Due to an increase in the company’s credit with facilities finance institutions to facilitate the expansion of the business. Net profit (loss) The company recorded a net loss of 198.57 million
selling medical equipment 108.10 63.62 Administrative expenses 99.81 104.41 Finance costs 23.47 23.13 Finance costs (net) 21.16 20.58 Proportion of cost of medical treatment / revenue of medical treatment
) Total Revenues from sales and services 1,471.69 1,387.47 6.07 Total Expenses 1,375.31 1,305.77 5.33 Finance Costs 23.78 26.51 (10.30) Profit before Income Tax Expenses 84.23 70.81 18.95 Income Tax
) Specific Business Tax 1,167 3.8 1,221 3.8 (54) (4.4) Finance Cost 731 2.4 641 2.0 90 14.0 Income Tax 1,708 5.6 1,890 6.1 (182) (9.6) Total 7,110 23.3 7,845 23.7 (431) (5.4) In the year 2018, the Company’s
398.21 314.81 Administrative expenses 460.64 414.05 Loss from Impairment of Investment 56.89 - Finance costs 61.87 92.81 Finance costs (net) 46.22 83.33 Proportion of cost of medical treatment / revenue of